⌕
Lemaitre Vascular · LMAT · Nasdaq
Tenet 68 · Solid
Compare
$77.01−1.63%At closeTenet 68 · Solid
$77.01−1.28 (−1.63%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Lemaitre Vascular (LMAT) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineSteady: revenue compounds ~12.8%/yr (FY21→FY25), net margin 23.1%, and free cash flow (~$74.5M) tracks net income. Earnings are cash, not paper. Worth your attention in FY25: Share count (+6.8%). Visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲13.5%
249.6
FY21→FY25CAGR +12.8%/yr
Net income ($M)▲31.1%
57.7
FY21→FY25CAGR +21.0%/yr
Free cash flow ($M)▲100.4%
74.5
FY21→FY25CAGR +25.3%/yr
Diluted EPS▲30.6%
2.52
FY21→FY25CAGR +19.2%/yr
What the receipts whisper · what a headline number hides
Share count
+6.8%

21.5mn → 22.9mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.

Capex
$6.8M

steady at 2.7% of revenue (−2.6% YoY).

Returns vs FCF
27%

$19.9M returned vs $74.5M of FCF in FY25. Buybacks + dividends covered by cash flow.

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)249.6Revenue−71.1COGS178.5Gross profit−14.1R&D−42.0SG&A67.9Op income−10.2Tax & other57.7Net income

23¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.

Margin trend · direction beats level Gross Operating Net
806040200%sector median net margin ~4%FY21FY25

Over this window: gross 65.7% → 71.5%. Net margin 23.1% is more than double the sector median.

The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
269,356.0249,602.0219,863.0193,484.0161,651.0154,424.0▲13.5%+12.8%
Cost of revenue
75,301.071,063.068,962.066,435.056,755.053,042.0▲3.0%+7.6%
Gross profit
194,055.0178,539.0150,901.0127,049.0104,896.0101,382.0▲18.3%+15.2%
Research & development
16,861.014,139.015,650.016,966.013,294.011,801.0▼9.7%+4.6%
Selling, general & admin
45,630.042,024.036,258.031,832.028,745.025,501.0▲15.9%+13.3%
Total operating expenses
119,354.0110,627.098,645.090,337.078,067.064,957.0▲12.1%+14.2%
Operating incomefeeds ROC rank
74,701.067,912.052,256.036,712.026,829.036,425.0▲30.0%+16.9%
Other income, net
7,134.07,272.04,619.02,763.0661.0−2,138.0——
Pretax income
81,835.075,184.056,875.039,475.027,490.034,287.0▲32.2%+21.7%
Income tax
18,500.017,450.012,837.09,370.06,854.07,380.0▲35.9%+24.0%
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings
63,335.057,734.044,038.030,105.020,636.026,907.0▲31.1%+21.0%
Per share
Diluted EPSbuyback-sensitive
2.762.521.931.340.931.25▲30.6%+19.2%
Diluted shares (mn)
23.0722.9322.7822.4222.1721.48▲0.7%+1.7%
Margins
Gross margin62nd pct in Healthcare
72.0%71.5%68.6%65.7%64.9%65.7%▲2.9pp+5.9pp
Operating margin
27.7%27.2%23.8%19.0%16.6%23.6%▲3.4pp+3.6pp
Net margin88th pct in Healthcare
23.5%23.1%20.0%15.6%12.8%17.4%▲3.1pp+5.7pp
† TTM = trailing four quarters through 2026-09-30.
FY09 – FY20 · 12 more years
Unlock the full history →
5 more years of statements and CSV export are on Premium, and 12 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-26 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was Lemaitre Vascular's revenue last fiscal year?

Lemaitre Vascular reported revenue of $249.6M in fiscal 2025, up 13.5% from fiscal 2024.

What was Lemaitre Vascular's net income?

Lemaitre Vascular reported net income of $57.7M in fiscal 2025, a net margin of 23.1%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.